Penerangan produk
Indikasi
LETEDX CMV DNA , • 6 6 (HSCT) CMV [R+] (CMV) • 12 40 CMV / CMV [D+/R-] CMV
Mekanisme Tindakan
12.1 Mekanisme Tindakan PREVYMIS CMV [ 12.4 ]
Farmakologi
12 12.1 Mekanisme Tindakan PREVYMIS (CMV) [ (12.4)] 12.2 QT , 2 , QTc 12.3 12 12 PREVYMIS (ADME) , 90% PREVYMIS 480 mg , 34,400 (16,900, 73,700) 480 mg , 100,000 (65,300,
Dos dan Cara Penggunaan
• (HSCT) 30 12 , 40 12 o (HSCT) , 480 , (IV) , 1 , 100 (CMV) ,LETEDX 200 o , 480 , , 1 , 200 • (HSCT) 6 12 , 12 30 o (HSCT) , , 1 , 100 (CMV) ,LETEDX 200 • LETEDX , (HSCT) CMV • LETEDX , 12 LETEDX 240 , 12 LETEDX ,
Langkah Berjaga-jaga
5 Langkah Berjaga-jaga PREVYMIS , PREVYMIS PREVYMIS , (4, 5.1, 7.1, 7.2, 7.3) PREVYMIS PREVYMIS , 4
Kontraindikasi
LETEDX • • •
Interaksi Ubat
7 PREVYMIS , 12 PREVYMIS 240 mg (2.4) PREVYMIS 12 , (2.6) PREVYMIS , PREVYMIS , , 2.4 2.6 4 5.1 7.1 7.2 7.3 7.4 12.3 7.1 PREVYMIS 1B1/3 (OATP1B1/3) P- (P-gp) UDP- 1A1/3 (UGT)
Kesan Sampingan
• (HSCT) LETEDX 10% , 2% • LETEDX 10% , •
